2022 RIHN and Supplementary list for IVD tests published in France

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published.

In 2022, minor changes were introduced in the RIHN list of innovative tests: five codes were removed, comments for three codes for NGS sequencing were modified. In the Supplementary list, 29 codes were removed due to different reasons; two of these codes (for Anti-Müllerian hormone (AMH) and Search or quantification of the BCR-ABL1 fusion transcript by RT-PCR) were removed because of registration of these tests in the NABM catalog.

The full details in French can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).